Advertisement

Clinical and Experimental Nephrology

, Volume 13, Issue 2, pp 161–165 | Cite as

Hemolytic anemia after ABO nonidentical living donor kidney transplantation

  • Mohamed A. Bakr
  • Tarek M. Abbas
  • Amany Mustafa
  • Mohamed A. Ghoneim
Original Article

Abstract

Introduction

ABO compatible non-identical kidney transplants are used frequently. Acquired hemolytic anemia has been reported after ABO mismatched transplantation. Patients of A, B or AB blood groups may receive organs from ABO-compatible, but non-identical donors, mostly from O blood group donors. It may also occur in patients of the AB blood group who receive a kidney from a donor of the A or B blood groups.

Patients and methods

ABO non-identical living donor kidney transplantation was done in 214 cases. All studied patients received kidneys from one haplotype HLA mismatched living donors and had pretransplant non-specific blood transfusions. There were 164 males and 50 females with a mean age of 30 years. Ten patients with cyclosporine (CsA)-based therapy developed hemolysis. CsA was stopped in patients maintained on triple immunosuppression (pred, CsA, AZA) and shifted to azathioprine in patients maintained on pred CsA therapy. In all patients pretransplant antibody screen, direct antiglobulin test (DAT) and cytotoxic cross match were all negative.

Results

The prognosis was excellent in nine patients, and one died from severe hemolysis. Hemolytic anemia was more frequent among blood group A recipients (60% of our cases) and more severe among recipient blood group B. Six patients received antigen-negative packed RBCs.

Univariate analysis demonstrated significant impact for recipient age, donor sex, number of pretransplant blood transfusions, primary immunosuppression, time to onset of diuresis, recipient and donor blood groups. Multivariate analysis restricted the significance to blood group of donor and recipient, time to onset of diuresis and primary immunosuppression.

Conclusions

Post transplant hemolysis is infrequent after renal transplantation; however, it may occur with compatible, non-identical ABO blood group donors. Blood group of donor and recipient, time to onset of diuresis and primary immunosuppression (mainly CsA) were significant risk factors in hemolytic anemia in patients after ABO non-identical living donor kidney transplantation. The condition is usually mild and self limited, and change of immunosuppression (stop CsA) can treat the condition.

Keywords

Kidney transplantation ABO non-identical Hemolysis 

References

  1. 1.
    Sokol RJ, Stamps R, Booker DJ, et al. Posttransplant immune-mediated hemolysis. Transfusion. 2002;42:198–204.CrossRefPubMedGoogle Scholar
  2. 2.
    Petz LD. Immune hemolysis associated with transplantation. Semin Hematol. 2005;42:145–55.CrossRefPubMedGoogle Scholar
  3. 3.
    Ramsey G. Red cell antibodies arising from solid organ transplants. Transfusion. 1991;31:76–86.CrossRefPubMedGoogle Scholar
  4. 4.
    Mangal AK, Growe GH, Sinclair M, Stillwell GF, Reeve CE, Naiman SC. Acquired hemolytic anemia due to “auto”- anti-A or “auto”-anti-B induced by group O homograft in renal transplant recipients. Transfusion. 1984;24:201–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Rougier JP, Viron B, Ronco P, Khayat R, Michel C, Mignon F. Autoimmune haemolytic anaemia after ABO match, ABDR full match kidney transplantation. Nephrol Dial Transplant. 1994;9:693–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Debska-Slizien A, Chamienia A, Krol E, et al. Hemolytic anemia after renal transplantation: analysis of case reports. Transplant Proc. 2003;35:2233–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Peces R, Navascues RA, Laures AS, et al. Alloimmune haemolytic anaemia resulting from anti-A and anti-B antibody induced by group O graft in renal transplant recipients. Nephrol Dial Transplant. 1998;13:1866–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Borka P, Jakab J, Rajczy K, et al. Temporary donor-derived B-lymphocyte microchimerism leading to hemolysis in minor ABO-incompatible renal transplantation. Transplant Proc. 2001;33:2287–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Tiplady CW, Fitzgerald JM, Jackson GH, Conn JS, Proctor SJ. Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant. Transfus Med. 2001;11:455–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Sternberg AJ, Lee G, Croxton T, et al. Severe haemolysis after an ABO unmatched kidney transplant—a non secretor transplanted from a donor with high anti-A titre. Transfus Med. 2000;10:87–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Sevaux RG, Dijk BA, Wetzels JF, Koene RA. Haemolysis after kidney trans-plantation: beware of the graft. Nephrol Dial Transplant. 1998;13:512–4.CrossRefPubMedGoogle Scholar
  12. 12.
    Thomson AW. The effects of cyclosporin A on non-T cell components of the immune system. J Autoimmun. 1992;5:167–76.CrossRefPubMedGoogle Scholar
  13. 13.
    Peters DH, Fitton A, Plosker GL, Faulds D. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs. 1993;46:746–94.CrossRefPubMedGoogle Scholar
  14. 14.
    Greeno EW, Perry EH, Ilstrup SJ, Weisdorf DJ. Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. Transfusion. 1996;36:71–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Hongeng S, Tardtong P, Worapongpaiboon S, Ungkanont A, Jootar S. Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab. Bone Marrow Transplant. 2002;29:871–2.CrossRefPubMedGoogle Scholar
  16. 16.
    Panaro F, DeChristopher PJ, Rondelli D, et al. Severe hemolytic anemia due to passenger lymphocytes after living related bowel transplant. Clin Transplant. 2004;18:332–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Bevan PC, Seaman M, Tolliday B, Chalmers DG. ABO haemolytic anaemia in transplanted patients. Vox Sang. 1985;49:42.CrossRefPubMedGoogle Scholar
  18. 18.
    Watzke H, Kovarik J. Gassner H: a permissive effect of cyclosporin on the development of isohaemagglutinins of graft origin in ABO-mismatched organ transplantation. Nephrol Dial Transplant. 1988;3(1):89–90.PubMedGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2009

Authors and Affiliations

  • Mohamed A. Bakr
    • 1
  • Tarek M. Abbas
    • 1
  • Amany Mustafa
    • 1
  • Mohamed A. Ghoneim
    • 1
  1. 1.Urology and Nephrology CenterMansoura UniversityMansouraEgypt

Personalised recommendations